Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Women with high BP face greater risk for dementia later in life

High blood pressure may put women at greater risk for dementia later in life by increasing white matter abnormalities in the brain, report researchers from the University of Pittsburgh Graduate School of Public Health in a study published online in the Journal of Clinical Hypertension.

12 Jan 2010

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation's Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer's disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these positive data would promote the use of Dimebon throughout the course of the disease.

12 Jan 2010

Prescribing culture of antipsychotic medications in nursing homes examined

Older adults newly admitted to nursing homes with high rates of antipsychotic prescribing in the previous year are more likely to receive antipsychotic agents, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Of these treated patients, some had no identified clinical indication for this therapy.

12 Jan 2010

Abe's Garden raises $3.5M to include a facility to care for adults with Alzheimer's disease

Abe's Garden, a non-profit organization that seeks to establish a national model of residential living and daycare programs for those suffering with Alzheimer's disease, has raised $3.5 million toward its $9 million capital campaign announced today.

12 Jan 2010

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics today outlined the Company's three key strategic priorities and presented a corporate outlook for 2010 at the 28th Annual J.P. Morgan Healthcare Conference.

12 Jan 2010

Atypical antipsychotic use for treating elderly patients with dementia decreases

The use of atypical antipsychotics to treat elderly patients with dementia appears to have decreased following a 2005 Food and Drug Administration (FDA) advisory regarding the risks of these medications in this population, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Jan 2010

DSG teams up with pharmaceutical technology company to speed early detection of major diseases

DSG, a leader in electronic data capture (EDC) has teamed up with a leading-edge pharmaceutical technology company to speed the early detection of Alzheimer’s, Parkinson’s, and Diabetes.

12 Jan 2010

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

Cancer of the gullet, or oesophagus, is one of the ten most common cancers in the Western world, and there have been recent alarming increases in the number of cases each year in the US and UK.

12 Jan 2010

Cognitively stimulating activities are beneficial, but mental exercises help some more than others

If you don't have a college degree, you're at greater risk of developing memory problems or even Alzheimer's. Education plays a key role in lifelong memory performance and risk for dementia, and it's well documented that those with a college degree possess a cognitive advantage over their less educated counterparts in middle and old age.

12 Jan 2010

University of Haifa receives grant to investigate role of protein expression in memory formation

Prof. Kobi Rosenblum, Head of the Department of Neurobiology and Ethology at the University of Haifa, has been awarded a -1.6 million grant from DIP, a German-Israeli Project Cooperation, over a five-year period. This grant will fund Prof. Rosenblum's international research of the role of protein expression in memory formation and stability.

12 Jan 2010

Exercise may improve cognitive function

Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition, according to two reports in the January issue of Archives of Neurology, one of the JAMA/Archives journals.

11 Jan 2010

Targacept signs collaboration and license agreement with AstraZeneca

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

11 Jan 2010

New technique may help researchers to test amyloid hypothesis in AD development

Current Alzheimer's disease (AD) research indicates that accumulation of amyloid-beta (Aβ) protein plaques in the brain is central to the development of AD.

11 Jan 2010

Selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference

“This year’s BIO CEO & Investor Conference will provide a unique forum to showcase therapeutic areas with key catalysts – from new and dynamic therapies to cutting edge investment opportunities,” said Alan Eisenberg, executive vice president of Emerging Companies & Business Development at BIO.

9 Jan 2010

UCF research opens a new exploratory path for Alzheimer's disease

Despite a massive global research effort, many basics of Alzheimer's disease onset remain elusive. This has hampered development of treatments effective during the earliest stages of the disease, when prevention is most likely.

9 Jan 2010

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

LinkMed’s portfolio company Likvor has received a new order for Likvor CELDA™ ,this time from Sahlgrenska University Hospital in Gothenburg. With Likvor CELDA™ the clinical will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow in a controlled and safe process.

9 Jan 2010

John C. Lechleiter to deliver keynote address on human dimensions of medical innovation

John C. Lechleiter, PhD, Chairman, President & CEO, Eli Lilly and Company, will deliver a keynote address, "Lifespans and Livelihoods: The Human Dimensions of Medical Innovation," to TOWN HALL Los Angeles on Thursday, January 14, 2010 at the Millennium Biltmore Hotel.

8 Jan 2010

Subjective cognitive impairment in healthy older adults can increase risk for dementia

Forgot where you put your car keys? Having trouble recalling your colleague's name? If so, this may be a symptom of subjective cognitive impairment (SCI), the earliest sign of cognitive decline marked by situations such as when a person recognizes they can't remember a name like they used to or where they recently placed important objects the way they used to.

8 Jan 2010

Scientists identify gene underlying a disease that causes temporary paralysis of skeletal muscle

Scientists have identified a gene underlying a disease that causes temporary paralysis of skeletal muscle. The finding, they say, illustrates how investigations of rare genetic diseases can drive insights into more common ones.

8 Jan 2010

University Hospitals Case Medical Center conducts Phase 2 clinical trial of gene therapy for AD

University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer's disease (AD). The study uses a viral-based gene transfer system called CERE-110, which is designed to deliver nerve growth factor (NGF) into the brain.

8 Jan 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Women with high BP face greater risk for dementia later in life

Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billion

Prescribing culture of antipsychotic medications in nursing homes examined

Abe's Garden raises $3.5M to include a facility to care for adults with Alzheimer's disease

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Atypical antipsychotic use for treating elderly patients with dementia decreases

DSG teams up with pharmaceutical technology company to speed early detection of major diseases

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

Cognitively stimulating activities are beneficial, but mental exercises help some more than others

University of Haifa receives grant to investigate role of protein expression in memory formation

Exercise may improve cognitive function

Targacept signs collaboration and license agreement with AstraZeneca

New technique may help researchers to test amyloid hypothesis in AD development

Selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference

UCF research opens a new exploratory path for Alzheimer's disease

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

John C. Lechleiter to deliver keynote address on human dimensions of medical innovation

Subjective cognitive impairment in healthy older adults can increase risk for dementia

Scientists identify gene underlying a disease that causes temporary paralysis of skeletal muscle

University Hospitals Case Medical Center conducts Phase 2 clinical trial of gene therapy for AD

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in